NEUROENDOCRINE NEOPLASMS
Clinical trials for NEUROENDOCRINE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE NEOPLASMS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo targets tough lung cancers in early trial
Disease control OngoingThis early-phase study tests a new combination of two drugs, obrixtamig and ezabenlimab, in adults with advanced small cell lung cancer or other neuroendocrine tumors that have not responded to prior treatments. The main goal is to find the highest safe dose of obrixtamig when gi…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 17, 2026 01:28 UTC
-
New drug combo targets hard-to-treat neuroendocrine cancer in early trial
Disease control OngoingThis early-phase study tests a new medicine (BI 764532) given with standard chemotherapy for people with advanced neuroendocrine carcinoma (NEC) whose tumors have a specific marker (DLL3). The main goals are to find safe doses and see if the combination helps shrink tumors. About…
Matched conditions: NEUROENDOCRINE NEOPLASMS
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC